Skip to content

Standardize the future of the biopharmaceutical industry with BioPhorum Technology Strategy

Standardize the future of the biopharmaceutical industry with BioPhorum Technology Strategy

Join 30+ global companies and 230+ participants collaborating to enable flexible, resilient and sustainable end-to-end solutions that ensure global access to essential medicines. 

BioPhorum Technology Strategy mission

Lead the transformation of biomanufacturing by enabling flexible, resilient, sustainable end-to-end
future biomanufacturing solutions
that ensure global access to
essential medicines
.

Members collaborate through focused Strategic Programs to deliver these future-ready solutions:

Future of Manufacturing Operations (FoMO): Defining the vision, roadmap, and visualization of key enabling technologies

Digital Technology Transfer: Developing a playbook to enable standardized digital tech transfer across global networks

Integrated Digital Twin: Establishing the framework for process and plant digital twins to optimize manufacturing performance

Future Technology Skills: Identifying and addressing the evolving skill requirements for the future biomanufacturing workforce.

BioPhorum Technology Strategy mission

Lead the transformation of biomanufacturing by enabling flexible, resilient, sustainable end-to-end future biomanufacturing solutions that ensure global access to essential medicines.

Members collaborate through focused Strategic Programs to deliver these future-ready solutions:

Future of Manufacturing Operations (FoMO): Defining the vision, roadmap, and visualization of key enabling technologies

Digital Technology Transfer: Developing a playbook to enable standardized digital tech transfer across global networks

Integrated Digital Twin: Establishing the framework for process and plant digital twins to optimize manufacturing performance

Future Technology Skills: Identifying and addressing the evolving skill requirements for the future biomanufacturing workforce.

A strategic asset for future operations: the FoMO Maturity Matrix

As a core output of the FoMO program, the forthcoming maturity matrix tool establishes a common language to navigate five levels of development, from manual operations to fully autonomous, lights-out facilities.

Members utilize this framework to drive industry recognition of goals and improve progress tracking, resource allocation, and decision-making processes by:

  • Informing capital expenditure (CapEx) strategy and prioritization

  • Future-proofing and de-risking technology investments

  • Supporting the choice of site selection for new product modalities

  • Mapping compatibility across the four key dimensions of the matrix: process, plant, people and sustainability. 

FOMO 1
Level 1: Current Cloud/platform integration and real-time data collection enabled by Quality by Design (QbD). 
FOMO 2
Level 2: Potential Descriptive digital twins using real-time sensors for remote diagnosis and knowledge-graph analysis. 
FOMO 3
Level 3: Optimized Holistic process and plant digital twins incorporating real-time analytics and integrated QbD data. 
FOMO 4
Level 4: Aspirational Automated technology transfer of recipes, parameters, and methods to streamline global transitions. 
FOMO 5
Level 5: Disruptive Fully autonomous lights-out facilities featuring predictive capacity, self-correcting control, and real-time release.
Digital twins w download icon
Catalyzing change w download icon
Digital twins

Defining digital twins in a biomanufacturing environment

Catalyzing change in biomanufacturing: From industry pressure to future-ready operations

The future of manufacturing operations, technology strategy maturity matrix for process and plant for large-scale biomanufacturing

Horizontal Digital twins w download icon (1)

Defining digital twins in a biomanufacturing environment

Horizontal Catalyzing change w download icon (1)

Catalyzing change in biomanufacturing: From industry pressure to future-ready operations 

Horizontal FoMO w download icon (1)

How the Future Manufacturing Operations matrix is guiding the industry’s transformation  

_90% stat

Faster virus and mycoplasma testing:
Enable faster adoption of rapid methods suitable for lot release testing

$16.5 sat

Estimated time and material savings:
Using on-demand manufacture over traditional methods of buffer prep
 

66% stat

Annual savings per site:
Realized through integrated digital twins

Join BioPhorum Technology Strategy to shape the standards and ensure relevance to your needs.